Preimplantation Genetic Diagnosis Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Preimplantation Genetic Diagnosis Market
Preimplantation Genetic Diagnosis Market: By Technology (PCR, CGH, FISH and NGS); By Product (Instrument, Reagent); By End User (Hospital, Diagnostic Lab & Others); By Application (HLA Typing, Cancer & Single Gene Disorders) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0265
Updated Date: 16 May, 2018  

1. Preimplantation Genetic Diagnosis Market – Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Preimplantation Genetic Diagnosis Market–Forces
   4.1. Drivers
      4.1.1. Increasing preference for personalized medicine
      4.1.2. Growing awareness related to genetic techniques
   4.2. Restraints
      4.2.1. Higher cost of treatment
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Preimplantation Genetic Diagnosis Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life cycle Analysis
   5.5. Suppliers & Distributors
6. Preimplantation Genetic Diagnosis Market, By Technology
   6.1. Polymerase Chain Reaction (PCR)
   6.2. Next Generation Sequencing (NGS)
   6.3. Fluorescence In-situ Hybridization (FISH)
   6.4. Comparative Genomic Hybridization (CGH) 
7. Preimplantation Genetic Diagnosis Market, By Product
   7.1. Instrument
   7.2. Reagent
8. Preimplantation Genetic Diagnosis Market, By End-User 
   8.1. Hospital
   8.2. Diagnostic Lab
   8.3. Research Lab
   8.4. Academia  
9. Preimplantation Genetic Diagnosis Market, By Application
   9.1. HLA Typing
   9.2. Inheritable Genetic Disorders
   9.3.  Chromosomal Abnormalities
   9.4. Single Gene Disorders
   9.5. Gender Identification
   9.6. Sex Linked Disorders
10. Preimplantation Genetic Diagnosis Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Brazil
      10.4.2. Rest of RoW
11. Preimplantation Genetic Diagnosis – Market Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Abbott Laboratories, Inc. (U.S.)
   12.2. F. Hoffmann-La Roche. Ltd. (Switzerland)
   12.3. Genesis Genetics, LLC (U.S.)
   12.4. Illumina, Inc. (U.S.)
   12.5. Laboratory Corporation of America Holdings (U.S.)
   12.6. Natera, Inc. (U.S.)
   12.7. PerkinElmer, Inc. (U.S.)
   12.8. Quest Diagnostics, Inc. (U.S.)
   12.9. Reproductive Genetics Institute (U.S.)
   12.10. Reprogenetics LLC (U.S.)
* More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibiliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll